| |
Ipratropium bromide (N* = 7)
|
|---|
|
Age in Years [Mean (SD)]
|
62.1 (5.98)
|
|
Male [n (%)]
|
3 (43)
|
|
BMI (kg/m2) [Mean (SD)]
|
31.11 (3.191)
|
|
Height (cm) [Mean (SD)]
|
168.71 (16.039)
|
|
FVC [Mean (SD)]
|
2.58 (1.161)
|
|
% predicted FVC [Mean (SD)]
|
73.75 (12.863)
|
|
FEV1 [Mean (SD)]
|
2.12 (0.773)
|
|
% predicted FEV1 [Mean (SD)]
|
77.07 (11.256)
|
|
MDT diagnosis of study completers
|
Study completers (N = 5)
|
|---|
|
IPF/probable IPF [n (%)]
|
3 (60)
|
|
NSIP/fibrotic NSIP [n (%)]
|
2 (40)
|
- BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume at 1 s, MDT multidisciplinary team, IPF idiopathic pulmonary fibrosis, NSIP non-specific interstitial pneumonia
- Note 1: *One participant had to be re-enrolled
- Note 2: As this was a non-quantitative, proof of concept study the impact of the participant’s characteristics was not designed to be taken into consideration
